1 | --- | --- | --- | --- | |------------------------------------------|-------|----------------------------------------------|--------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | | Addressing RAS Pathway Blockade & Resistance | | | | | | VS-6766 & Defactinib Combination Data in KRAS Mutant Solid Tumors Investor Conference Call and Webcast | | | | | | | PROPERTY OF VERASTEM, INC. NASDAQ: VSTM | | | April 27, 2020 | Speakers 805 Ver ...